Pacific Biosciences of California Inc [PACB] is -42.62% lower this YTD. Is it still time to buy?
Pacific Biosciences of California Inc [NASDAQ: PACB] price surged by 6.32 percent to reach at $0.06. The one-year PACB stock forecast points to a potential upside of 45.88. The average equity rating for PACB stock is currently 2.27, trading closer to a bullish pattern in